tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Vogel, 5 are a BUY (100%).
Analyst Adam Vogel, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 66.67% that have a potential upside of 110.45% achieved within 175 days.
Adam Vogel’s has documented 10 price targets and ratings displayed on 2 stocks.
Most recent stock forecast was given on IMNM, Immunome at 03-Mar-2026.
Analyst best performing recommendations are on APGE (APOGEE THERAPEUTICS).
The best stock recommendation documented was for IMNM (IMMUNOME) at 9/5/2025. The price target of $26 was fulfilled within 150 days with a profit of $15.48 (147.15%) receiving and performance score of 9.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2026
$40
$23.53 (142.87%)
$40
1 months 13 days ago
(10-Sep-2026)
0/2 (0%)
$15.03 (60.19%)
Buy Since 18-Dec-2023
$35
$18.53 (112.51%)
$31
2 months 11 days ago
(12-Aug-2026)
2/10 (20%)
$7.01 (25.04%)
14
Buy Since 02-Apr-2025
$30
$13.53 (82.15%)
$32
7 months 18 days ago
(04-Mar-2026)
1/3 (33.33%)
$9.05 (43.20%)
258
Buy Since 08-Nov-2024
$30
$10.04 (50.30%)
$33
7 months 19 days ago
(04-Mar-2026)
0/4 (0%)
$7.48 (33.21%)
Buy Since 05-Sep-2025
$36
$16.04 (80.36%)
$33
7 months 19 days ago
(04-Mar-2026)
1/3 (33.33%)
$13.48 (59.86%)
150
What Year was the first public recommendation made by Adam Vogel?
